Eton Pharmaceuticals, Inc.
ETON
$58.83
-$0.52-0.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 547.89% | 198.85% | 347.99% | -407.34% | 15.00% |
| Total Depreciation and Amortization | 37.91% | 11.65% | 186.48% | 262.95% | 260.22% |
| Total Amortization of Deferred Charges | 233.33% | -59.86% | -83.16% | 713.64% | 108.70% |
| Total Other Non-Cash Items | -24.58% | -14.50% | 137.05% | 227.60% | 286.48% |
| Change in Net Operating Assets | -235.55% | 2,285.09% | -501.38% | 704.35% | 96.91% |
| Cash from Operations | -8.85% | 254.31% | -1,409.93% | 307.38% | 534.18% |
| Capital Expenditure | -- | -- | -308.33% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 99.87% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 252.54% | -94.90% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 252.54% | -98.75% | 100.00% | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.74% | -352.86% | -109.93% | 357.42% | 666.03% |